CD44 and melanoma: Knock-down of CD44 in breast and melanoma tumors, and targeted knock-down of COX2 in non-transformed healthy myeloid cells and mouse embryonic fibroblasts were also able to increase the numbers and functional activation of NK cells [29,39,42,43].